Drug recall · July 13, 2022
Eszopiclone Tablets recall
Why: Shortfill: customer complaints of one to three tablets were reported missing from 30 count bottles.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Eszopiclone Tablets, USP 1 mg, packaged in 30-count bottles, Rx Only, Manufactured for: Macleods Pharma USA, Inc., Plainsboro, NJ 08536, Manufactured by: Macleods Pharmaceuticals Ltd., Baddi, Himachal Pradesh, INDIA, NDC 33342-299-07
- Lots / codes
Lot #: BEK2009A Exp: 11/2023
- Quantity
- 168690 Tablets
- Company
- Macleods Pharma Usa Inc, Plainsboro, NJ
- Distribution
- Distributed Nationwide and Puerto Rico.
- Initiated
- June 16, 2022 · Voluntary: Firm initiated
- Classified
- July 5, 2022
- Reported
- July 13, 2022
- Ended
- March 20, 2024
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Eszopiclone
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.